MedTrace Logo

Medical Marijuana in the Pediatric Central Nervous System Tumor Population

NCT03052738 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2024-08-29

No results posted yet for this study

Summary

This study proposes to do a prospective observational cohort study evaluating the quality of life (QOL) of children with Central Nervous System (CNS) tumors and their families who choose to self-medicate with marijuana-derived products while undergoing treatment at Children's Hospital Colorado (CHCO).

Conditions

  • Central Nervous System Tumor
  • Brain Tumor
  • Spinal Tumor

Sponsors & Collaborators

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Nicholas K Foreman, MD · University of Colorado, Denver

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-15
Primary Completion
2020-06-30
Completion
2020-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03052738 on ClinicalTrials.gov